Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1965 Aug;44(8):1287–1294. doi: 10.1172/JCI105235

Responses of the Normal Human to Infusions of Plasma from Patients with Graves' Disease*

Claude D Arnaud 1,, Hans A Kneubuhler 1,, Virginia L Seiling 1, Bruce K Wightman 1, Norman H Engbring 1
PMCID: PMC292607  PMID: 14322036

Full text

PDF
1287

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS D. D. Bioassay of long-acting thyroid stimulator (L.A.T.S.); the dose-response relationship. J Clin Endocrinol Metab. 1961 Jul;21:799–805. doi: 10.1210/jcem-21-7-799. [DOI] [PubMed] [Google Scholar]
  2. ADAMS D. D., PURVES H. D., SIRETT N. E. The response of hypophysectomized mice to injections of human serum containing long-acting thyroid stimulator. Endocrinology. 1961 Jan;68:154–155. doi: 10.1210/endo-68-1-154. [DOI] [PubMed] [Google Scholar]
  3. ADAMS D. D., PURVES H. D. The role of thyrotrophin in hyperthyroidism and exophthalmos. Metabolism. 1957 Jan;6(1):26–35. [PubMed] [Google Scholar]
  4. ADAMS D. D. The presence of an abnormal thyroid-stimulating hormone in the serum of some thyrotoxic patients. J Clin Endocrinol Metab. 1958 Jul;18(7):699–712. doi: 10.1210/jcem-18-7-699. [DOI] [PubMed] [Google Scholar]
  5. BAKKE J., LAWRENCE N., ROY S. Disappearance rate of exogenous thyroid-stimulating hormone (TSH) in man. J Clin Endocrinol Metab. 1962 Apr;22:352–363. doi: 10.1210/jcem-22-4-352. [DOI] [PubMed] [Google Scholar]
  6. BERSON S. A., YALOW R. S. Quantitative aspects of iodine metabolism: the exchangeable organic iodine pool, and the rates of thyroidal secretion, peripheral degradation and fecal excretion, of endogenously synthesized organically bound iodine. J Clin Invest. 1954 Nov;33(11):1533–1552. doi: 10.1172/JCI103032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BJORKMAN S. E., DENNEBERG T., HEDENSKOG I. Clinical evaluation of the thyroid stimulating hormone activity in exophthalmos. Acta Endocrinol (Copenh) 1961 Dec;38:577–584. doi: 10.1530/acta.0.0380577. [DOI] [PubMed] [Google Scholar]
  8. MCKENZIE J. M., FISHMAN J. Effects of antiserum in bioassay of thyrotropin and thyroid activator of hyperthyroidism. Proc Soc Exp Biol Med. 1960 Oct;105:126–128. doi: 10.3181/00379727-105-26032. [DOI] [PubMed] [Google Scholar]
  9. MCKENZIE J. M. Studies on the thyroid activator of hyperthyroidism. J Clin Endocrinol Metab. 1961 Jun;21:635–647. doi: 10.1210/jcem-21-6-635. [DOI] [PubMed] [Google Scholar]
  10. MEEK J. C., JONES A. E., LEWIS U. J., VANDERLAAN W. P. CHARACTERIZATION OF THE LONG-ACTING THYROID STIMULATOR OF GRAVES' DISEASE. Proc Natl Acad Sci U S A. 1964 Aug;52:342–349. doi: 10.1073/pnas.52.2.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McKENZIE J. M. Delayed thyroid response to serum from thyrotoxic patients. Endocrinology. 1958 Jun;62(6):865–868. doi: 10.1210/endo-62-6-865. [DOI] [PubMed] [Google Scholar]
  12. McKENZIE J. M. The bioassay of thyrotropin in serum. Endocrinology. 1958 Sep;63(3):372–382. doi: 10.1210/endo-63-3-372. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES